相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 AMHR2 抗体 (莫伦妥单抗),生物类似药,科研用途 [ CAS: 2058047-65-5]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
AMHR2
- 抗体名:
AMHR2
- 规格:
5mg
BioSIM 抗人 AMHR2 抗体 (莫伦妥单抗),生物类似药
产品概述
BioSIM anti-Human AMHR2 Antibody (Murlentamab Biosimilar), Research Grade 是一种高品质的人源化抗体,专为科研用途设计。该抗体是莫伦妥单抗的生物类似药,针对抗米勒管激素受体2(AMHR2)具有高特异性识别能力,产品编号为 SIM0464-5mg,规格为5mg。
产品特性
- 产品类型:二抗
- CAS编号:2058047-65-5
- 来源宿主:人源化(Humanized)
- 反应性:人类(Human)
- 研究领域:结直肠癌(CRC)研究
生产与纯化工艺
该重组生物类似抗体采用先进的生物技术生产,具有以下特点:
- 在无动物成分的设施中生产,确保高纯度和安全性
- 使用体外的无蛋白细胞培养技术,减少潜在污染风险
- 经过多步骤的纯化过程,包括采用Protein A或G的色谱工艺,确保抗体的高纯度和活性
应用领域
BioSIM抗人AMHR2抗体适用于多种科研应用,包括:
- ELISA:酶联免疫吸附测定
- FACS:流式细胞术
- Functional assay:功能性实验
- Research in vivo:体内研究
储存建议
为确保抗体活性和稳定性,请遵循以下储存条件:
- 避免反复冻融,以保持抗体活性
- 短期需求(1-2周):请在4°C下保存
- 最长12个月的储存:请在-20°C下保存
- 长期储存:请在-80°C下保存
关于免疫原性
该BioSIM抗人AMHR2抗体的免疫原性信息请参考产品说明书。建议在使用前仔细阅读相关资料,以确保实验设计的合理性和安全性。
供应商信息
本产品由InvivoCrown公司提供,该公司致力于为全球科研工作者提供高质量的生物试剂和抗体产品。
科研价值
AMHR2(抗米勒管激素受体2)在结直肠癌等疾病的研究中具有重要价值。BioSIM抗人AMHR2抗体作为莫伦妥单抗的生物类似药,为研究人员提供了一种经济高效的工具,用于探索AMHR2在癌症生物学中的作用机制,以及开发针对该靶点的潜在治疗策略。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM anti-Human AMHR2 Antibody (Murlentamab Biosimilar)
Product Overview
BioSIM anti-Human AMHR2 Antibody (Murlentamab Biosimilar), Research Grade is a high-quality humanized antibody designed specifically for research purposes. This antibody is a biosimilar of Murlentamab with high specificity for Anti-Müllerian Hormone Receptor 2 (AMHR2). The product number is SIM0464-5mg with a specification of 5mg.
Product Characteristics
- Product Type: Secondary Antibody
- CAS Number: 2058047-65-5
- Source Host: Humanized
- Reactivity: Human
- Research Area: Colorectal Cancer (CRC) Research
Production and Purification Process
This recombinant biosimilar antibody is produced using advanced biotechnology with the following features:
- Produced in animal component-free facilities to ensure high purity and safety
- Uses protein-free cell culture technology in vitro to reduce potential contamination risks
- Undergoes a multi-step purification process, including chromatography with Protein A or G, to ensure high purity and activity of the antibody
Application Areas
BioSIM anti-Human AMHR2 Antibody is suitable for various research applications, including:
- ELISA: Enzyme-Linked Immunosorbent Assay
- FACS: Flow Cytometry
- Functional assay: Functional Assays
- Research in vivo: In Vivo Research
Storage Recommendations
To maintain antibody activity and stability, please follow the storage conditions below:
- Avoid repeated freeze-thaw cycles to maintain antibody activity
- For short-term needs (1-2 weeks): Store at 4°C
- For storage up to 12 months: Store at -20°C
- For long-term storage: Store at -80°C
About Immunogenicity
Please refer to the product insert for immunogenicity information of this BioSIM anti-Human AMHR2 Antibody. It is recommended to carefully read relevant materials before use to ensure the rationality and safety of experimental design.
Supplier Information
This product is provided by InvivoCrown, a company committed to providing high-quality biological reagents and antibody products to researchers worldwide.
Research Value
AMHR2 (Anti-Müllerian Hormone Receptor 2) has significant value in the study of diseases such as colorectal cancer. As a biosimilar of Murlentamab, BioSIM anti-Human AMHR2 Antibody provides researchers with a cost-effective tool for exploring the mechanism of action of AMHR2 in cancer biology and developing potential therapeutic strategies targeting this receptor.
Note: The above information may change due to factors such as product optimization and upgrades. For specific information, please consult Yakeyin Company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料





